Literature DB >> 27262173

AIMP2 Controls Intestinal Stem Cell Compartments and Tumorigenesis by Modulating Wnt/β-Catenin Signaling.

Min Kyu Yum1, Jong-Seol Kang1, Al-Eum Lee2, Young-Woo Jo1, Ji-Yun Seo1, Hyun-A Kim1, Yoon-Young Kim1, Jinwoo Seong1, Eun Byul Lee1, Ji-Hoon Kim1, Jung Min Han3, Sunghoon Kim4, Young-Yun Kong5.   

Abstract

Wnt/β-catenin (CTNNB1) signaling is crucial for the proliferation and maintenance of intestinal stem cells (ISC), but excessive activation leads to ISC expansion and eventually colorectal cancer. Thus, negative regulators are required to maintain optimal levels of Wnt/β-catenin signaling. Aminoacyl-tRNA synthetase-interacting multifunctional proteins (AIMP) function in protein synthesis, but have also been implicated in signaling cascades affecting angiogenesis, immunity, and apoptosis. In this study, we investigated the relationship between AIMP2 and Wnt/β-catenin signaling in a murine model of intestinal homeostasis and tumorigenesis. Hemizygous deletion of Aimp2 resulted in enhanced Wnt/β-catenin signaling, increased proliferation of cryptic epithelial cells, and expansion of ISC compartments. In an Apc(Min/+) background, Aimp2 hemizygosity increased adenoma formation. Mechanistically, AIMP2 disrupted the interaction between AXIN and Dishevelled-1 (DVL1) to inhibit Wnt/β-catenin signaling by competing with AXIN. Furthermore, AIMP2 inhibited intestinal organoid formation and growth by suppressing Wnt/β-catenin signaling in an Aimp2 gene dosage-dependent manner. Collectively, our results showed that AIMP2 acts as a haploinsufficient tumor suppressor that fine-tunes Wnt/β-catenin signaling in the intestine, illuminating the regulation of ISC abundance and activity. Cancer Res; 76(15); 4559-68. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27262173     DOI: 10.1158/0008-5472.CAN-15-3357

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Evolution of the multi-tRNA synthetase complex and its role in cancer.

Authors:  Do Young Hyeon; Jong Hyun Kim; Tae Jin Ahn; Yeshin Cho; Daehee Hwang; Sunghoon Kim
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

Review 2.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

3.  Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development.

Authors:  Semi Lim; Hye Young Cho; Dae Gyu Kim; Younah Roh; Se-Young Son; Ameeq Ul Mushtaq; Minkyoung Kim; Deepak Bhattarai; Aneesh Sivaraman; Youngjin Lee; Jihye Lee; Won Suk Yang; Hoi Kyoung Kim; Myung Hee Kim; Kyeong Lee; Young Ho Jeon; Sunghoon Kim
Journal:  Nat Chem Biol       Date:  2019-12-02       Impact factor: 15.040

4.  Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer.

Authors:  Ji Ye Jung; Eun Young Kim; Arum Kim; Joon Chang; Nam Hoon Kwon; Youngji Moon; Eun Joo Kang; Jun Sik Sung; Hyunbo Shim; Sunghoon Kim; Yoon Soo Chang
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

5.  Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.

Authors:  Qidi Zheng; Zhuojia Lin; Jie Xu; Yanan Lu; Qiuyu Meng; Chen Wang; Yuxin Yang; Xiaoru Xin; Xiaonan Li; Hu Pu; Xin Gui; Tianming Li; Wujun Xiong; Dongdong Lu
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

6.  An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody.

Authors:  Dae Gyu Kim; Thi Thu Ha Nguyen; Nam Hoon Kwon; Junsik Sung; Semi Lim; Eun-Joo Kang; Jihye Lee; Woo Young Seo; Arum Kim; Yoon Soo Chang; Hyunbo Shim; Sunghoon Kim
Journal:  Biomolecules       Date:  2020-05-27

Review 7.  Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Dongsheng Yu; Xiaochuan Zhang
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

8.  PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.

Authors:  Yue Zhao; Qijue Lu; Chunguang Li; Xinyu Wang; Long Jiang; Lei Huang; Chao Wang; Hezhong Chen
Journal:  Cell Death Dis       Date:  2019-05-01       Impact factor: 8.469

9.  Retinol Promotes In Vitro Growth of Proximal Colon Organoids through a Retinoic Acid-Independent Mechanism.

Authors:  Taichi Matsumoto; Wakana Mochizuki; Yoichi Nibe; Shintaro Akiyama; Yuka Matsumoto; Kengo Nozaki; Masayoshi Fukuda; Ayumi Hayashi; Tomohiro Mizutani; Shigeru Oshima; Mamoru Watanabe; Tetsuya Nakamura
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

10.  Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.

Authors:  Jayoung Ku; Ryul Kim; Dongchan Kim; Daeyoon Kim; Seulki Song; Keonyong Lee; Namseok Lee; MinA Kim; Sung-Soo Yoon; Nam Hoon Kwon; Sunghoon Kim; Yoosik Kim; Youngil Koh
Journal:  Commun Biol       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.